Brevan Howard Capital Management’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$844K Sell
22,775
-9,185
-29% -$294K 0.01% 1000
2025
Q4
$645K Buy
31,960
+18,024
+129% +$436K 0.01% 973
2025
Q3
$420K Buy
+13,936
New +$302K ﹤0.01% 1382

Other funds holding AEHR

Brevan Howard Capital Management's AEHR Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its Aehr Test Systems (AEHR) stake by 29% in Q1 2026, selling an estimated $294K and leaving 22,775 shares worth $844K. The position accounts for 0.01% of the portfolio, ranked #1000.

Brevan Howard Capital Management first reported a position in AEHR in Q3 2025 and has held it in 3 quarters since. 191 funds tracked by Wall St. Rank hold AEHR as of Q1 2026.

  • Brevan Howard Capital Management held 22,775 shares of Aehr Test Systems worth $844K as of Q1 2026.
  • Brevan Howard Capital Management sold 9,185 Aehr Test Systems shares in Q1 2026, an estimated $294K.
  • Aehr Test Systems made up 0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1000 holding.
  • Brevan Howard Capital Management first reported a position in Aehr Test Systems in Q3 2025 and has held it in 3 quarters since.
  • 191 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.